Litigation Details for CORCEPT THERAPEUTICS, INC. v. HIKMA PHARMACEUTICALS USA INC. (D.N.J. 2021)
✉ Email this page to a colleague
CORCEPT THERAPEUTICS, INC. v. HIKMA PHARMACEUTICALS USA INC. (D.N.J. 2021)
| Docket | ⤷ Start Trial | Date Filed | 2021-03-12 |
| Court | District Court, D. New Jersey | Date Terminated | 2022-12-09 |
| Cause | 35:271 Patent Infringement | Assigned To | Evelyn Padin |
| Jury Demand | None | Referred To | Leda Dunn Wettre |
| Patents | 10,166,242; 10,166,243; 10,195,214; 10,500,216; 10,842,800; 10,842,801; 8,859,774; 8,921,348; 9,943,526 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in CORCEPT THERAPEUTICS, INC. v. HIKMA PHARMACEUTICALS USA INC.
The small molecule drugs covered by the patents cited in this case are ⤷ Start Trial and ⤷ Start Trial .
Details for CORCEPT THERAPEUTICS, INC. v. HIKMA PHARMACEUTICALS USA INC. (D.N.J. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-03-12 | External link to document | |||
| 2021-03-11 | 1 | Complaint | United States Patent Nos. 10,195,214 (“the ʼ214 Patent”), 10,500,216 (“the ʼ216 Patent”), 10,842,800 … claims of the ’214 Patent, the ’216 Patent, the ʼ800 Patent, and the ʼ801 Patent are invalid, unenforceable…10,842,800 (“the ʼ800 Patent), and 10,842,801 (“the ʼ801 Patent”) (together, “the patents-in-suit”), owned by … This complaint is an action for patent infringement under the patent laws of the United States, 35 U.S.C…Notice Letter alleges that the claims of the patents-in-suit patent are invalid and/or will not be infringed | External link to document |
| 2021-03-11 | 57 | Redacted Document | States Patent Nos. 10,195,214, 10,500,216, 10,842,800, and 10,842,801 (together, “the patents-in-suit…product before the patents-in-suit expire, which Corcept alleges is an act of patent infringement under…. Summary of the Claims and Defenses This is a patent infringement case arising from Hikma filing an …counterclaims, seeking declaratory judgments that the patents-in-suit are (1) not infringed and (2) invalid or…2021 9 December 2022 2:21-cv-05034 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2021-03-11 | 66 | Letter | infringement of certain claims of United States Patent Nos. 10,195,214; 10,500,216; 10,842,800; and 10,842,801… the expiration of the Asserted Patents was a technical act of patent infringement with respect to one… the Asserted Patents would infringe one or more claims of each of the Asserted Patents unless and to…Court has subject matter jurisdiction over this patent infringement action (the “Action”) and has personal…10,842,801 (together, the “Asserted Patents”) in connection with Hikma’s submission of Abbreviated New Drug | External link to document |
| 2021-03-11 | 67 | Judgment | infringement of certain claims of United States Patent Nos. 10,195,214; 10,500,216; 10,842,800; and 10,842,801… the expiration of the Asserted Patents was a technical act of patent infringement with respect to one… the Asserted Patents would infringe one or more claims of each of the Asserted Patents unless and to…Court has subject matter jurisdiction over this patent infringement action (the “Action”) and has personal…10,842,801 (together, the “Asserted Patents”) in connection with Hikma’s submission of Abbreviated New Drug | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
